Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis Ego Seeman Review Article 19 March 2003 Pages: 2 - 8
Optimizing bone metabolism in osteoporosis: insight into the pharmacologic profile of strontium ranelate P. J. Marie Review Article 18 March 2003 Pages: 9 - 12
The mineralization of bone tissue: a forgotten dimension in osteoporosis research G. BoivinP. J. Meunier Review Article 18 March 2003 Pages: 19 - 24
Is the calcium receptor a molecular target for the actions of strontium on bone? Edward M. Brown Review Article 12 March 2003 Pages: 25 - 34
Bone matrix proteins: their function, regulation, and relationship to osteoporosis Marian F. Young Review Article 12 March 2003 Pages: 35 - 42
Assessment of prevalent and incident vertebral fractures in osteoporosis research H. K. GenantM. Jergas Review Article 12 March 2003 Pages: 43 - 55
Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies J. Y. ReginsterP. J. Meunier Review Article 12 March 2003 Pages: 56 - 65
Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosis P. J. MeunierJ. Y. Reginster Original Article 12 March 2003 Pages: 66 - 76